Skip to main content

Table 6 Recovery test of solid phase spectrophotometric determination of salicylate derivatives (n = 3, P = 0.95)

From: Silica-titania xerogel for solid phase spectrophotometric determination of salicylate and its derivatives in biological liquids and pharmaceuticals

Analyte

Sample

Added (mM)

Found (mM)

RSD  (%)

Recovery  (%)

Methylsalicylate

Deep heat creama

0

1.01 ± 0.24

13.6

 

0.91

1.85 ± 0.27

8.2

92.3

1.82

2.83 ± 0.24

4.9

100.0

Acetylsalicylic acid

Acetylsalicylic acid tablets Medisorb

0

0.57 ± 0.06

6.4

 

0.55

1.07 ± 0.06

3.4

90.9

1.1

1.68 ± 0.06

2.2

100.9

Acetylsalicylic acid tablets Tatkhim

0

0.69 ± 0.09

7.6

 

0.55

1.20 ± 0.09

4.5

92.7

1.1

1.79 ± 0.09

2.9

100.0

Citramon tabletsb

0

0.49 ± 0.09

10.6

 

0.55

1.02 ± 0.15

7.7

96.4

1.1

1.58 ± 0.15

5.8

99.1

  1. aContains additional active substances: menthol 59.1 mg/g, eucalyptus oil 19.7 mg/g, turpentine oil 14.7 mg/g
  2. bContains additional active substances: paracetamol 180 mg/tablet, caffeine 30 mg/tablet